A recent study conducted of patients with multiple sclerosis showed that a change could be coming in the field. Just as patients said they wanted to be more involved in their choice of treatment options, their healthcare professionals said they encouraged feedback from the patients.
As part of the overall picture of multiple sclerosis treatment optic neuritis is one of the early stages of the condition. The studies looked at sodium channels that show promise for future multiple sclerosis patients even if it is not in the field.
Chronic conditions like multiple sclerosis require constant monitoring by doctors and patients, As time goes on medication and treatment options may need to be changed. Tecfidera, one popular treatment option has become a popular choice in patient care.
New evidence has made it easier to differentiate between multiple sclerosis and vanishing white matter disease, conditions that can show considerable similarities.
Lemtrada (alemtuzumab) injection is approved for the management of relapsing forms of multiple sclerosis (MS). In general, use of Lemtrada should be limited to patients with MS who have not had therapeutic success with 2 or more prior treatments.
Researchers report that mice with experimental allergic encephalomyelitis (an animal model of brain inflammation that is used to study multiple sclerosis) that were fed a diet that included cinnamon powder experienced a reduction in symptom severity.
Although multiple sclerosis is likely a result of multifactorial influences, there is some evidence that viruses play a role in the disease.
Researchers will adapt an existing video game therapy for multiple sclerosis patients to slow progression of motor decline.
The FDA issued a safety warning for the MS drug Tecfidera after a patient died from a rare brain disease while taking no other medications.
The launch of MS Radio aims to spread information, host discussions, and present features for multiple sclerosis patients, caregivers, and clinicians.
Ann Romney announced the launch of a neurologic center in collaboration with Brigham and Women's Hospital in Boston, set to open in 2016.
Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
Doses of prepared human placenta culture cells are safe for multiple sclerosis patients, according to a study published in Multiple Sclerosis and Related Disorders.
Fumaric acid esters (FAEs) are a known component of a centuries-old herbal medicine, have been used for over 50 years as a topical treatment for psoriasis, and most recently, have demonstrated efficacy in treating relapsing- remitting multiple sclerosis.
The autoimmune system may not be the primary location for multiple sclerosis development, according to a study published in Science Translational Medicine.
Researchers in Saint Louis are examining the ways in which a drug already approved for multiple sclerosis could ease some of the pain associated with chemotherapy for cancer patients.
Coping strategies based on enhanced mindfulness and a greater sense of agency can help patients improve their quality of life.
Clinicians can use the MSPT, an iPad-based neurological performance test that simulates and extends the Multiple Sclerosis Functional Composite, to measure motor and visual function in patients with multiple sclerosis.
Physicians must consider a range of factors when initiating treatment with disease-modifying drug therapy and be prepared to switch to another first- or second-line option if the patient fails to respond.
Treating patients with multiple sclerosis who opt to use only supplements and other complementary and alternative approaches requires a great deal of tact and education, and input and support from all members of the multidisciplinary treatment team.
